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Background: This retrospective study was designed to determine the efficacy of broad-spectrum antibacterials
combined with percutaneous renal drainage in the treatment of emphysematous pyelonephritis (EPN).
Methods: From July 1992 to September 2002, 10 patients (nine females and one male) with EPN were managed
at our institution. All patients had diabetes and presented with fever and chills, flank pain or tenderness, vomiting,
and altered consciousness. The diagnosis of EPN was confirmed by the presence of intraparenchymal and/or
perinephric gas in imaging studies (kidney-ureter-bladder film, sonogram, and/or computed tomography scan). Broad-
spectrum antibacterial therapy, combined with percutaneous renal drainage, was started in all patients. Follow-up
studies consisted of computed tomography scan and technetium-labeled diethylenetriaminepentaacetic acid (DTPA)
radioisotope renography.
Results: The outcome was good in all patients. Three patients underwent delayed nephrectomy due to non-functioning
of the involved kidney. The DTPA radioisotope renography results (glomerular filtration rate of the diseased kidney/
contralateral healthy kidney) were 0/57 mL/min, 2.7/68.1 mL/min and 3.7/63.9 mL/min.
Conclusion: Combined broad-spectrum antibacterial therapy and percutaneous renal drainage is a safe and effective
treatment for EPN, especially in high-risk patients for whom nephrectomy under general anesthesia is not feasible.
[J Chin Med Assoc 2005;68(1):29–32]
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Introduction
Emphysematous pyelonephritis (EPN) is an un-
common, life-threatening disease resulting from
acute suppurative infection of the kidneys. It usually
occurs in females with diabetes, with or without ob-
structive uropathy. The prominent disease characteris-
tic is gas accumulation in the renal parenchyma, collect-
ing system, or perinephric tissue. Clinical signs and
symptoms are often similar to those of uncomplicat-
ed pyelonephritis, e.g. fever, flank pain, nausea, and
vomiting.1
Recently, Wan et al classified EPN into two types,
based on findings from computed tomography (CT)
studies: type I is characterized by extensive destruction
of the renal parenchyma, with a large collection of air,
but no fluid; type II, on the other hand, is marked by
the presence of air and a large amount of fluid in the
renal parenchyma, collecting system, or perinephric
tissue.2 These investigators also reported that the
mortality rate was higher in type I than type II patients
(69% vs 18%).2 Surgical drainage or nephrectomy,
with blood-sugar control and appropriate antibacterial
schedules, are the treatments of choice.1,3–9
We report 10 cases of EPN (three type I, and seven
type II) that responded favorably to percutaneous
renal drainage and broad-spectrum antibacterial
therapy.
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Methods
From July 1992 to September 2002, 10 consecutive
patients with documented EPN, confirmed by plain
abdominal radiograph, CT scan and/or ultrasound,
were seen at our institution. The patients’ demographic
and clinical data, including age, gender, signs and
symptoms, results of laboratory tests, EPN type and
location, and treatment strategies, were obtained by
chart review. Information about outcomes, including
complications, post-treatment kidney function, and
overall satisfaction with treatment, was also collected
from medical records. Follow-up studies, comprising
CT scan and technetium-labeled diethylenetriamine-
pentaacetic acid (DTPA) radioisotope renography,
were performed.
Results
Mean patient age was 61.2 years (range, 53–79 years).
There were 9 females and 1 male, all with a history of
diabetes mellitus. Symptoms and signs on admission
included fever (9/10), chills (7/10), flank pain or ten-
derness (6/10), vomiting (2/10), and altered con-
sciousness (1/10). Laboratory tests showed positive
cultures of pus (8/10), blood (5/10) and urine
(5/10); thrombocytopenia (1/10) and hematuria
(1/10) were also noted. One patient had a creatinine
level of 1.8 mg/dL, whereas this parameter was less
than 1.4 mg/dL in the other patients. All patients
satisfied the imaging criteria of a gas-filled lesion in the
renal parenchyma, collecting system, or perinephric
space, and demonstrated by a plain kidney-ureter-
bladder film (Figure 1), CT scan (Figures 2 and 3),
and/or ultrasound (Figure 4). There were 3 type I
and 7 type II cases confirmed by CT scan. The
most common organism isolated from cultures was
Escherichia coli (6/10) (Table). More than 1 infecting
organism was identified in 3 patients: E. coli and
Figure 1. Plain abdominal, kidney-ureter-bladder film showing a
large, crescent-shaped air density (arrow) in the right upper quadrant.
Figure 2. Type I emphysematous pyelonephritis: computed
tomography scan of the abdomen showing abnormal gas, without
fluid, collection in the right kidney (small arrow) and perirenal
space (arrow).
Figure 3. Type II emphysematous pyelonephritis: computed
tomography scan of the abdomen showing acute pyelonephritis of
the left kidney, with confluent gas collection in the renal parenchyma
and perirenal abscess (arrow).
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Proteus mirabilis (n = 2); and E. coli and Klebsiella
pneumoniae (n = 1).
Percutaneous renal drainage in the prone position
was performed in all patients. A 10-Fr pigtail tube was
placed in the renal parenchyma, collecting system, or
perinephric space, under ultrasound guidance. An
additional 12-Fr pigtail catheter was positioned in 4
patients because of a residual lesion detected on follow-
up CT scan 2 days later. All patients were also initially
given a first-generation cephalosporin (cefazolin) plus
gentamicin. The antibacterials were then changed to
ceftriaxone or ceftazidime, according to culture findings,
administered for 9–21 days (mean, 13.6 days). Blood
glucose levels were controlled with insulin. Catheters
were removed when drainage was less than 10 mL and
follow-up CT scans showed no residual lesions.
All patients recovered well, and no mortality oc-
curred. However, 3 patients with a non-functioning
kidney underwent nephrectomy 6 weeks after percu-
taneous renal drainage.
Discussion
EPN is an uncommon, life-endangering disease caused
by suppurative infection of the renal parenchyma and
peripheral tissues. Most cases are associated with
uncontrolled diabetes mellitus, but there have been
reports of non-diabetic patients with ureteral obstruc-
tion.1,7 The clinical symptoms of EPN are similar to
those of acute pyelonephritis unresponsive to medical
treatment.1 Although E. coli is the most commonly
reported pathogen, Proteus, Pseudomonas, Klebsiella,
Enterobacter, and Candida spp. have also been reported
as causative organisms.1,2,10
In 1998, Wan and colleagues classified EPN into
two types based on CT findings.2 These researchers
also reported that the mortality rate was greater in type
I than type II patients (69% vs 18%), and that the
rate increased markedly (92% vs 53%) in patients with
a serum creatinine level > 1.4 mg/dL and throm-
bocytopenia (platelets < 60,000/mm3).2 In our series,
we had 3 patients with a type I lesion and 7 with a
type II lesion; all patients survived. The zero mortality
may have been due to early diagnosis (creatinine <
1.4 mg/dL), and treatment with percutaneous drainage
and broad-spectrum antibacterials.
The mechanism for gas production in EPN is not
yet well understood. One theory is that, in uncontrolled
diabetes, glucose fermentation by the offending or-
ganism provides an excellent microenvironment for
the organism’s growth and rapid catabolism, leading
to the massive production of carbon dioxide and
hydrogen.1,7,11 Because of impaired gaseous transport,
carbon dioxide and hydrogen accumulate in tissues,
leading to tissue infarction and, thus, to further damage
to the renal parenchyma.11 In cases of unrelieved uri-
nary tract obstruction, urinary stasis leads to severe
infection, and increased intra-pelvicalyceal pressure
compromises and impairs the renal circulation, result-
ing in poor tissue perfusion, which makes antibacterial
therapy ineffective.
CT scan has been advocated as the most useful
modality for diagnosing EPN and guiding percutaneous
renal drainage.5–8 Some authors reported that percu-
taneous drainage under sonoguide was not suitable
for patients with gas-producing infection, because the
significant distal shadowing and reverberation artifact
produced by ultrasound made it difficult to determine
the exact placement of the drainage catheter.10 In our
experience, however, ultrasound not only clearly dem-
onstrates the gas and fluid collection, but is also use-
ful in guiding placement of the percutaneous drainage
catheter. We successfully used ultrasound-guided
percutaneous renal drainage in treating our patients.
Reports on the therapeutic approach for patients
with EPN suggest that the mortality rate in patients
managed medically is greater than that in patients
Figure 4. Ultrasound of the right kidney showing a well-defined
hyperechoic lesion (arrows) with associated dark shadowing.
Table. Most common organism isolated from cultures of
patients with emphysematous pyelonephritis
Organism isolated n (%)
Escherichia coli 6 (60)
Klebsiella pneumoniae 3 (30)
Proteus mirabilis 2 (20)
Pseudomonas aeruginosa 1 (10)
Enterobacter spp. 1 (10)
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managed surgically,1,2,7 while combined treatment has
produced a survival rate of more than 90%.1 Some
researchers have claimed that immediate nephrectomy
is necessary, since delayed operation may only increase
mortality.12 Conversely, several patients have been
treated successfully with percutaneous drainage, con-
trol of diabetes, and institution of broad-spectrum
antibacterial therapy.4–8,10 This regimen is thought to
be a life-saving alternative for the critically ill and for
high-risk patients, who are not suitable candidates for
nephrectomy under general anesthesia. In our series,
all patients recovered: 3 patients underwent delayed
nephrectomy due to non-functioning of the affected
kidney. Therefore, early, adequate percutaneous
drainage, combined with broad-spectrum antibacterial
therapy is not only life-saving, but is also a kidney-
salvage procedure. If prompt resolution of the gas
collection or clinical improvement does not occur,
open drainage or nephrectomy must be done
immediately;6,7 delayed operation may jeopardize the
chances of survival.
EPN is a rare and life-threatening condition that
needs early diagnosis and intervention to salvage the
affected kidney. CT scan and ultrasound are both
sensitive tools for diagnosis and for guiding catheter
insertion for percutaneous renal drainage. The
combination of broad-spectrum antibacterial therapy
and percutaneous renal drainage seems to be safe and
effective for the treatment of EPN.
References
1. Michaeli J, Magle P, Perlberg S, Heiman S, Caine M. Emphy-
sematous pyelonephritis. J Urol 1984;131:203–8.
2. Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of
outcome in emphysematous pyelonephritis. J Urol 1998;159:
369–73.
3. Koh KBH, Lam HS, Lee SH. Emphysematous pyelonephritis:
Drainage or nephrectomy? Br J Urol 1993;71:609–11.
4. Shahatto N, Al Awadhi NZ, Ghazali S. Emphysematous pyelo-
nephritis: surgical implications. Br J Urol 1990;66:572–4.
5. Corr J, Leeson M, Wilson G, Grainger R. Percutaneous man-
agement of emphysematous pyelonephritis. Br J Urol 1993;71:
487–8.
6. Hudson MA, Weyman PJ, Van der Vliet AH, Catalona WJ.
Emphysematous pyelonephritis: successful management by
percutaneous drainage. J Urol 1986;136:884–6.
7. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clini-
coradiological classification, management, prognosis, and
pathogenesis. Arch Intern Med 2000;160:797–805.
8. McHugh TP, Albanna SE, Stewart NJ. Bilateral emphysematous
pyelonephritis. Am J Emerg Med 1998;16:166–9.
9. Stein JP, Spita A, Elmajian DA, Freeman JA, Grossfeld GD,
Ginsberg DA, Skinner DG. Bilateral emphysematous pyelo-
nephritis: a case report and review of the literature. Urology
1996;47:129–34.
10. Kuo YT, Chen MT, Liu GC, Huang CN, Huang CL, Huang
CH. Emphysematous pyelonephritis: imaging diagnosis and
follow-up. Kaohsiung J Med Sci 1999;15:159–70.
11. Yang WH, Shen NC. Gas-forming infection of the urinary
tract: an investigation of fermentation as a mechanism. J Urol
1990;143:960–4.
12. Ahlering TE, Boyd SD, Hamilton CL, Bragain SD, Chandra-
soma PT, Leiskovsky G, Skinner DG. Emphysematous pyelo-
nephritis: a 5 year experience with 13 patients. J Urol 1985;
134:1086–8.
